White House OKs FDA asking for 2 months monitoring, likely delaying vaccine authorization past Election Day
By STEPHANIE EBBS, ABC News(WASHINGTON) -- The FDA has told companies working on COVID-19 vaccines it expects at least two months of follow up on clinical trial participants after they complete a full regimen of a vaccine, which likely means... Read More.
